At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
Pulsed Electric Field Ablationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for Atrial Fibrillation
In Brief
A clinical study evaluating Pulsed Electric Field Ablation for Atrial Fibrillation. Completed, enrolled 24 participants across 2 sites in 2 countries.
Detailed Summary
A prospective, single arm, multi-center exploratory study of safety and feasibility in the treatment of patients undergoing cardiothoracic surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesCzechia, Georgia
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMar 2021
Enrollment StartMay 2021
Primary CompletionJun 2022
Study CompletionApr 2023
TodayJul 2026
First PostedMar 1, 2021
Enrollment StartMay 17, 2021
Primary CompletionJun 17, 2022
Study CompletionApr 27, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.3 years ago
Interventions
Pulsed Electric Field Ablationprocedure
Catheter ablation of Ganglionated Plexi (GP) structures on the epicardial surface of the heart during cardiothoracic surgery